Priti Kenia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Priti Kenia has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Hollie Smith
Birmingham Women's and Children's NHS Foundation Trust Birmingham UK
2 shared publications - Prasad Nagakumar
Birmingham Women's and Children's NHS Foundation Trust Birmingham UK
2 shared publications - Caroline S. Pao
Queen Mary University of London London UK
1 shared publication - Clare Onyon
Worcestershire Acute Hospitals NHS Trust Worcester UK
1 shared publication - Deepa Patel
University Hospitals of Leicester NHS Trust Leicester UK
1 shared publication - Derick Yates
Birmingham Women's and Children's NHS Foundation Trust Birmingham UK
1 shared publication
Latest Publications
- Open Access
- 2 November 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (11) , e71892
United Kingdom Professional Consensus on Candidate Items and Domains for Age Specific Paediatric Bronchiectasis Quality of Life Questionnaires: An e‐Delphi Study
Background: Paediatric bronchiectasis (PB) unrelated to cystic fibrosis or primary ciliary dyskinesia causes significant morbidity and impairs quality of life (QoL) for children and their families. An international consensus ranked a paediatric‐specific QoL measure as the highest research priority, yet no self‐report instrument exists for children and young people. We aimed to establish professional consensus on candidate items and domains to inform the development of age specific PB QoL questionnaires. Methods: Candidate items were drawn verbatim from two validated paediatric respiratory instruments (QOL‐PCD and CFQ‐R), guided by published evidence. Multidisciplinary professionals from the Paediatric Bronchiectasis Network, United Kingdom (PBNetUK) rated items for child (6–12 years), young person (13–17 years) and parent proxy (6–12 years) over 2 e‐Delphi rounds (≥ 70% agreement). A core group, including a parent representative finalised item sets. Feasibility was checked with 30 patients and parents. Results: Of 34 professionals invited, 26, 21 and 20 rated the child (28 items), young person (36 items) and parent‐proxy (33 items) versions in round one; round two retention was 90%–96%. Final versions comprised 19, 27 and 20 items across eight domains, with a 4‐week recall period. For feasibility, participants rated length as appropriate (28/30) and items as easy to understand (mean 8.0–9.4/10). Conclusions: This professional consensus provides a candidate item pool and proposed domain framework that will guide the next stages of QoL questionnaire development ‐ establishing content validity through concept elicitation and cognitive interviews with children, young people and parents, followed by psychometric validation to produce a validated QoL.
- 2 November 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (11) , e71892
Open AccessUnited Kingdom Professional Consensus on Candidate Items and Domains for Age Specific Paediatric Bronchiectasis Quality of Life Questionnaires: An e‐Delphi Study
Background: Paediatric bronchiectasis (PB) unrelated to cystic fibrosis or primary ciliary dyskinesia causes significant morbidity and impairs quality of life (QoL) for children and their families. An international consensus ranked a paediatric‐specific QoL measure as the highest research priority, yet no self‐report instrument exists for children and young people. We aimed to establish professional consensus on candidate items and domains to inform the development of age specific PB QoL questionnaires. Methods: Candidate items were drawn verbatim from two validated paediatric respiratory instruments (QOL‐PCD and CFQ‐R), guided by published evidence. Multidisciplinary professionals from the Paediatric Bronchiectasis Network, United Kingdom (PBNetUK) rated items for child (6–12 years), young person (13–17 years) and parent proxy (6–12 years) over 2 e‐Delphi rounds (≥ 70% agreement). A core group, including a parent representative finalised item sets. Feasibility was checked with 30 patients and parents. Results: Of 34 professionals invited, 26, 21 and 20 rated the child (28 items), young person (36 items) and parent‐proxy (33 items) versions in round one; round two retention was 90%–96%. Final versions comprised 19, 27 and 20 items across eight domains, with a 4‐week recall period. For feasibility, participants rated length as appropriate (28/30) and items as easy to understand (mean 8.0–9.4/10). Conclusions: This professional consensus provides a candidate item pool and proposed domain framework that will guide the next stages of QoL questionnaire development ‐ establishing content validity through concept elicitation and cognitive interviews with children, young people and parents, followed by psychometric validation to produce a validated QoL.
- 13 February 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (2) , e71490
Pediatric Bronchiectasis Quality‐of‐Life Questionnaire—What Does the Literature Say?
Introduction: Bronchiectasis in children is a neglected chronic suppurative lung disease that imposes a substantial burden on children and adolescents and their families, adversely affecting quality of life (QoL). Incorporating health‐related quality of life (HRQoL) tools into routine care can improve outcomes by highlighting disease burden and guiding tailored interventions. This scoping review aimed to identify self‐reported questionnaires assessing QoL in pediatric bronchiectasis (PB). Methods: Following the PRISMA extension for scoping reviews, we searched Embase, CINAHL, MEDLINE, Cochrane Central Register of Controlled Trials, PsycINFO, and PubMed for articles published in English since 2000. Pre‐specified keywords (QoL, children, adolescents, bronchiectasis, lung disease, patient reported outcome measures (PROM), primary ciliary dyskinesia, cystic fibrosis) and related index terms were used. Studies employing questionnaires or items assessing QoL in children and adolescents with bronchiectasis were included without geographical restrictions. Two authors independently screened and appraised eligible manuscripts. Results: The search yielded 731 articles, of which 373 were relevant to respiratory diseases. Thirty‐three met inclusion criteria, identifying 15 unique HRQoL tools used in bronchiectasis or related conditions. Only five (33%) of these tools were developed for adults with bronchiectasis and no pediatric‐specific bronchiectasis HRQoL questionnaires were identified. Conclusion: This scoping review highlights the absence of any validated, pediatric‐specific HRQoL tools for bronchiectasis. Developing such a questionnaire, informed by existing instruments and our review findings, is an urgent priority. A validated tool will enhance understanding of disease impact on children, adolescents and their families, supporting tailored clinical care and research interventions.
- 13 February 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (2) , e71490
Pediatric Bronchiectasis Quality‐of‐Life Questionnaire—What Does the Literature Say?
Introduction: Bronchiectasis in children is a neglected chronic suppurative lung disease that imposes a substantial burden on children and adolescents and their families, adversely affecting quality of life (QoL). Incorporating health‐related quality of life (HRQoL) tools into routine care can improve outcomes by highlighting disease burden and guiding tailored interventions. This scoping review aimed to identify self‐reported questionnaires assessing QoL in pediatric bronchiectasis (PB). Methods: Following the PRISMA extension for scoping reviews, we searched Embase, CINAHL, MEDLINE, Cochrane Central Register of Controlled Trials, PsycINFO, and PubMed for articles published in English since 2000. Pre‐specified keywords (QoL, children, adolescents, bronchiectasis, lung disease, patient reported outcome measures (PROM), primary ciliary dyskinesia, cystic fibrosis) and related index terms were used. Studies employing questionnaires or items assessing QoL in children and adolescents with bronchiectasis were included without geographical restrictions. Two authors independently screened and appraised eligible manuscripts. Results: The search yielded 731 articles, of which 373 were relevant to respiratory diseases. Thirty‐three met inclusion criteria, identifying 15 unique HRQoL tools used in bronchiectasis or related conditions. Only five (33%) of these tools were developed for adults with bronchiectasis and no pediatric‐specific bronchiectasis HRQoL questionnaires were identified. Conclusion: This scoping review highlights the absence of any validated, pediatric‐specific HRQoL tools for bronchiectasis. Developing such a questionnaire, informed by existing instruments and our review findings, is an urgent priority. A validated tool will enhance understanding of disease impact on children, adolescents and their families, supporting tailored clinical care and research interventions.